Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ana M Mendes-Pereira

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Plos One|November 13, 2012
NLK is a novel therapeutic target for PTEN deficient tumour cellsAna M Mendes-Pereira, Christopher J Lord, Alan Ashworth
Molecular Cancer Therapeutics|July 26, 2013
Synthetic lethal targeting of PTEN-deficient cancer cells using selective disruption of polynucleotide kinase/phosphataseTodd R Mereniuk, Mohamed A M El Gendy, Ana M Mendes-Pereira, et al.
EMBO Molecular Medicine|January 6, 2010
Synthetic lethal targeting of PTEN mutant cells with PARP inhibitorsAna M Mendes-Pereira, Sarah A Martin, Rachel Brough, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 13, 2011
Genome-wide functional screen identifies a compendium of genes affecting sensitivity to tamoxifenAna M Mendes-Pereira, David Sims, Tim Dexter, et al.
Science Translational Medicine|October 15, 2010
PTEN deficiency in endometrioid endometrial adenocarcinomas predicts sensitivity to PARP inhibitorsKonstantin J Dedes, Daniel Wetterskog, Ana M Mendes-Pereira, et al.
Oncogene|June 29, 2022
Functional screening reveals HORMAD1-driven gene dependencies associated with translesion synthesis and replication stress toleranceDalia Tarantino, Callum Walker, Daniel Weekes, et al.
Genome Biology|October 25, 2011
High-throughput RNA interference screening using pooled shRNA libraries and next generation sequencingDavid Sims, Ana M Mendes-Pereira, Jessica Frankum, et al.
Cancer Discovery|October 11, 2011
Functional viability profiles of breast cancerRachel Brough, Jessica R Frankum, David Sims, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Plos One|November 13, 2012
NLK is a novel therapeutic target for PTEN deficient tumour cellsAna M Mendes-Pereira, Christopher J Lord, Alan Ashworth
Molecular Cancer Therapeutics|July 26, 2013
Synthetic lethal targeting of PTEN-deficient cancer cells using selective disruption of polynucleotide kinase/phosphataseTodd R Mereniuk, Mohamed A M El Gendy, Ana M Mendes-Pereira, et al.
EMBO Molecular Medicine|January 6, 2010
Synthetic lethal targeting of PTEN mutant cells with PARP inhibitorsAna M Mendes-Pereira, Sarah A Martin, Rachel Brough, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 13, 2011
Genome-wide functional screen identifies a compendium of genes affecting sensitivity to tamoxifenAna M Mendes-Pereira, David Sims, Tim Dexter, et al.
Science Translational Medicine|October 15, 2010
PTEN deficiency in endometrioid endometrial adenocarcinomas predicts sensitivity to PARP inhibitorsKonstantin J Dedes, Daniel Wetterskog, Ana M Mendes-Pereira, et al.
Oncogene|June 29, 2022
Functional screening reveals HORMAD1-driven gene dependencies associated with translesion synthesis and replication stress toleranceDalia Tarantino, Callum Walker, Daniel Weekes, et al.
Genome Biology|October 25, 2011
High-throughput RNA interference screening using pooled shRNA libraries and next generation sequencingDavid Sims, Ana M Mendes-Pereira, Jessica Frankum, et al.
Cancer Discovery|October 11, 2011
Functional viability profiles of breast cancerRachel Brough, Jessica R Frankum, David Sims, et al.
Pageof 1